MoneyWorks4Me

Fermenta Biotech - Quaterly Results

27 May 2024 Evaluate
A decrease in the sales to Rs. 896.55 millions was observed for the quarter ended March 2024. The sales stood at Rs. 1005.86 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2024 is Rs. -72.47 millions as compared to Net Loss of Rs. -21.10 millions of corresponding quarter ended March 2023The company reported a degrowth in operating Profit to 104.21 millions from 264.16 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 896.55 1005.86 -10.87 3070.90 3289.14 -6.64 3070.90 3289.14 -6.64
Other Income 14.98 10.70 40.00 81.54 84.62 -3.64 81.54 84.62 -3.64
PBIDT 104.21 264.16 -60.55 451.40 468.98 -3.75 451.40 468.98 -3.75
Interest 34.15 63.10 -45.88 170.52 208.02 -18.03 170.52 208.02 -18.03
PBDT 70.06 51.06 37.21 190.88 -334.93 -156.99 190.88 -334.93 -156.99
Depreciation 62.00 58.84 5.37 236.96 244.85 -3.22 236.96 244.85 -3.22
PBT 8.06 -7.78 -203.60 -46.08 -579.78 -92.05 -46.08 -579.78 -92.05
TAX 80.53 13.32 504.58 141.36 -9.74 -1551.33 141.36 -9.74 -1551.33
Deferred Tax 63.73 -11.52 -653.21 124.56 -11.56 -1177.51 124.56 -11.56 -1177.51
PAT -72.47 -21.10 243.46 -187.44 -570.04 -67.12 -187.44 -570.04 -67.12
Equity 144.37 144.29 0.06 144.37 144.29 0.06 144.37 144.29 0.06
PBIDTM(%) 11.62 26.26 -55.74 14.70 14.26 3.09 14.70 14.26 3.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..